14 studies found for:    glioblastoma | Open Studies | Interventional Studies | Phase 3
Show Display Options
Rank Status Study
1 Recruiting Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Radiotherapy;   Radiation: Experimental arm
2 Not yet recruiting Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Procedure: Standard surgery (neuronavigation-guided);   Radiation: Intraoperative radiotherapy;   Radiation: Radiochemotherapy;   Drug: Temozolomide
3 Not yet recruiting Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
Conditions: Glioblastoma;   Recurrence;   Progression
Interventions: Drug: Temozolomide;   Drug: Bevacizumab
4 Recruiting A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE)
Condition: Glioblastoma
Interventions: Drug: VB-111 + bevacizumab;   Drug: Bevacizumab
5 Recruiting Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo
6 Recruiting Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Glioblastoma;   Gliosarcoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Temozolomide;   Drug: Veliparib
7 Recruiting A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients
Condition: Recurrent Glioblastoma
Interventions: Biological: Nivolumab;   Biological: Bevacizumab;   Biological: Ipilimumab
8 Recruiting MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS
Condition: Glioblastoma
Interventions: Drug: 5-aminolévulinique acid (5-ALA);   Drug: Placebo
9 Not yet recruiting The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Conditions: GBM;   Depression
Interventions: Drug: Escitalopram;   Drug: placebo
10 Recruiting Study of Nivolumab Versus Temozolomide, Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Condition: Brain Cancer
Interventions: Drug: Nivolumab;   Drug: Temozolomide;   Radiation: Radiotherapy
11 Recruiting P2/3 Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Biological: Toca 511;   Drug: Toca FC;   Drug: Lomustine;   Drug: Temozolomide;   Biological: Bevacizumab
12 Recruiting A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Intervention: Drug: β-elemene
13 Recruiting A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: Temozolomide;   Drug: α-IFN
14 Unknown  Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Glioblastoma
Interventions: Drug: Carmustine;   Procedure: tumor resection surgery

Indicates status has not been verified in more than two years